Islam Khalid has filed 15 insider transactions across 2 companies since June 2023.
Most recent transaction: a grant/award of 15000 shares of Gain Therapeutics, Inc. ($GANX) on June 24, 2025.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 24, 2025 | Gain Therapeutics, Inc. | $GANX | Islam Khalid | Director | A | Stock Option (right to buy) | 15000 | $0.00 | 15,000.0000 | 28,685,417 | 9999.99% | 0.05% |
| June 3, 2025 | FENNEC PHARMACEUTICALS INC. | $FENC | Islam Khalid | Not found | A | Stock Option | 25000 | $7.88 | 225,000.0000 | 27,578,000 | 12.50% | 0.09% |
| Aug. 15, 2024 | FENNEC PHARMACEUTICALS INC. | $FENC | Islam Khalid | Not found | A | Stock Option | 25000 | $5.58 | 200,000.0000 | 27,297,000 | 14.29% | 0.09% |
| Aug. 9, 2024 | Gain Therapeutics, Inc. | $GANX | Islam Khalid | Executive Chairman | P | Common Stock | 50000 | $1.00 | 930,784.0000 | 19,215,582 | 5.68% | 0.26% |
| June 24, 2024 | Gain Therapeutics, Inc. | $GANX | Islam Khalid | Director | A | Stock Option (right to buy) | 15000 | $0.00 | 15,000.0000 | 17,978,951 | 9999.99% | 0.08% |
| Nov. 16, 2023 | FENNEC PHARMACEUTICALS INC. | $FENC | Islam Khalid | Not found | M | Common Shares | 10000 | $2.69 | 245,492.0000 | 26,596,000 | 3.91% | 0.04% |
| Nov. 16, 2023 | FENNEC PHARMACEUTICALS INC. | $FENC | Islam Khalid | Not found | M | Common Shares | 50000 | $1.13 | 195,492.0000 | 26,596,000 | 20.37% | 0.19% |
| Nov. 16, 2023 | FENNEC PHARMACEUTICALS INC. | $FENC | Islam Khalid | Not found | M | Common Shares | 20492 | $2.44 | 175,000.0000 | 26,596,000 | 10.48% | 0.08% |
| Nov. 16, 2023 | FENNEC PHARMACEUTICALS INC. | $FENC | Islam Khalid | Not found | M | Common Shares | 50000 | $1.13 | 193,333.0000 | 26,596,000 | 34.88% | 0.19% |
| Nov. 16, 2023 | FENNEC PHARMACEUTICALS INC. | $FENC | Islam Khalid | Not found | M | Common Shares | 133333 | $2.31 | 133,333.0000 | 26,596,000 | 9999.99% | 0.50% |
| Nov. 16, 2023 | FENNEC PHARMACEUTICALS INC. | $FENC | Islam Khalid | Not found | M | Common Shares | 10000 | $2.69 | 143,333.0000 | 26,596,000 | 7.50% | 0.04% |
| Nov. 16, 2023 | FENNEC PHARMACEUTICALS INC. | $FENC | Islam Khalid | Not found | M | Common Shares | 20492 | $2.44 | 213,825.0000 | 26,596,000 | 10.60% | 0.08% |
| Nov. 16, 2023 | FENNEC PHARMACEUTICALS INC. | $FENC | Islam Khalid | Not found | M | Common Shares | 133333 | $2.31 | 255,492.0000 | 26,596,000 | 34.29% | 0.50% |
| June 23, 2023 | Gain Therapeutics, Inc. | $GANX | Islam Khalid | Director | A | Stock Option (right to buy) | 10500 | $0.00 | 10,500.0000 | 11,935,081 | 9999.99% | 0.09% |
| June 12, 2023 | FENNEC PHARMACEUTICALS INC. | $FENC | Islam Khalid | Not found | A | Stock Option | 25000 | $0.00 | 388,825.0000 | 26,559,000 | 6.87% | 0.09% |